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Abstract
Introduction: The demographic transition in India has resulted in an increase in the elderly population. There is limited data
on the profile of elderly tuberculosis (TB) patients and their treatment outcomes in India.
Objective: To compare the clinical profile, presentation and response to anti-TB treatment among elderly ($60 yrs) and
younger (15–59 yrs) TB patients treated under the Revised National TB Control programme.
Methodology: Retrospective cohort analysis of TB patients treated from May 1999 to December 2004 in one Tuberculosis
Unit of Tiruvallur district, South India.
Results: Records of 865 elderly and 4343 younger TB patients were examined: elderly were more likely to be male (84% vs.
71%), smokers (46% vs.37%), illiterate (63% vs. 45%), identified by active case finding through survey (19% vs. 11%), have
pulmonary TB (96% vs. 91%) and initial smear negative disease (46% vs. 36%) compared to younger (for all p,0.001).
Among a total of 352 elderly and 1933 younger new smear positive pulmonary TB, the elderly had higher loss to follow-up
(15% vs. 11%; p = 0.03) and death rates (9% vs. 4%; p,0.001). Mycobacterium tuberculosis susceptibility to first line anti-TB
drugs did not differ (elderly 87% vs. younger 84%) (p = 0.20). Side effects related to anti-TB drugs were reported by a higher
proportion of elderly patients (63% vs. 54%) (p = 0.005). Previously treated patients had similar treatment outcomes in both
the groups.
Conclusion: Elderly TB patients are less likely to have smear positive disease. Newly diagnosed elderly TB patients are more
likely to be lost to follow-up or die and report drug side effects. Suitable interventions need to be developed for effective
management and better treatment outcomes of TB in the elderly.
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Introduction
The demographic transition in India has resulted in the label of
an ageing nation [1]. The Government of India’s ‘National Policy
on Older Persons’ defines ‘elderly’ as a person who is of age 60
years or above [2]. In 2001, the proportion of elderly in India was
about 7.4% of the overall population which increased to 8.3% in
2011 [2,3]. A decline in immunity and age related physiological
changes leads to an increased burden of communicable and non-
communicable diseases in the elderly [1].
India is the highest tuberculosis (TB) burden country accounting
for a quarter (26%) of the global incidence [4]. About 90% of TB
in the elderly is due to endogenous reactivation [5]. Co-
morbidities, inter-current illness, malnutrition, excess alcohol
use, underlying malignancy and the use of immunosuppressant
drugs can impair the cell-mediated immunity in the elderly
causing progression to TB disease [6]. New smear positive TB case
notification in India in those aged 55 yrs and above showed an
increase from 31133 to 132938 between the years 2000 to 2012
[4]. This increase in TB case notifications may partly be due to the
increase in the elderly population and is expected to rise further
since the proportion of elderly ($60 yrs) in India projected for
2026 is about 12.17% of the overall population [1]. A study from
South India has documented that older TB patients ($60 yrs)
accounted for 14% of all TB patients [7]. There is limited data on
the profile of elderly TB patients and their treatment outcomes in
India [7–12]. The objective of this study was to compare the
clinical profile, presentation and response to anti-TB treatment
among the elderly ($60 yrs) and younger (15–59 yrs) TB patients
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treated under the Revised National TB Control programme
(RNTCP).
Methodology
Study area and participants
This was a retrospective analysis of a cohort of TB patients
registered for anti-TB treatment from May 1999 to December
2004 in one Tuberculosis Unit (TU) of Tiruvallur District, Tamil
Nadu State, South India [Under the RNTCP, a TU is a sub-
district supervisory unit which covers on average a population of
500,000]. This TU has 17 government health care facilities
including seven designated microscopy centres.
National Institute for Research in TB (NIRT) (formerly
Tuberculosis Research Centre) was monitoring the TB pro-
gramme implemented by the Government of Tamil Nadu in one
TU of Tiruvallur district, since May 1999. TB cases were
diagnosed by testing symptomatic patients at health facilities
through the examination of three sputum smears for acid-fast
bacilli (passive screening). In addition, the centre was conducting
epidemiological surveys from 1999 to measure the prevalence of
TB (active screening) in this TU. Approval of the Ethics
Committee of NIRT was obtained and written informed consent
was obtained from all the patients (aged$18 yrs) and from
guardian/care-givers for those aged 15 to less than 18 yrs.
All patients diagnosed with TB were given directly observed
treatment in accordance with the RNTCP guidelines with first line
anti-TB drugs which include isoniazid (H), rifampicin (R),
pyrazinamide (Z), ethambutol (E) and streptomycin (S) [13].
Newly diagnosed TB patients received Category I (2H3R3Z3E3/
4H3R3) or Category III (2H3R3Z3/4H3R3) anti-TB regimens,
while previously treated TB patients received Category II regimen
(2H3R3Z3E3S3/1H3R3Z3E3/5H3R3E3) [13]. The treatment was
extended for one month if the smears were positive at the end of
the intensive phase (IP) in Categories I and II. Every dose of
treatment in IP, and at least the first of the three doses during the
continuation phase were given under supervision. Details of
patients who began treatment were noted in the register, and they
were monitored in accordance with the RNTCP guidelines [13].
Data collection
The information about type of disease (pulmonary or extra-
pulmonary), category of disease, grade of smear and baseline
weight (in kg) was obtained from the treatment cards. Two sputum
samples were collected from each patient for smear and culture on
Lowenstein Jensen (L-J) medium, within a week of treatment
initiation. The specimens that yielded growth were tested for drug
susceptibility. Resistance to H and R was determined by the
absolute concentration method minimum inhibitory concentration
(MIC) and to S by resistance ratio (RR) method [14,15]. MICs of
$5 mg/l and of $128 mg/l were defined as resistance to H and
R, respectively. A RR of $8 was considered as resistance to S
[16].
Within 8 weeks from the start of treatment, trained medical
social workers (MSW) interviewed patients using a structured
questionnaire to obtain information about education, co-morbid
conditions, personal habits, chest symptoms, care-seeking behav-
iour and drug related problems. MSW’s made three attempts to
contact each patient for the interview.
Upon completion of treatment, each patient’s treatment card
was again reviewed to collect information about follow-up sputum
smear results and treatment outcomes.
Case definitions
Patients aged $60 yrs were defined as elderly and those aged
15–59 years as younger. RNTCP definitions were used to classify
the type of TB, category and treatment outcomes [13].
Patients who could read and write were considered literate;
those who said they habitually consumed alcohol or smoked as
alcohol users or smokers respectively, patients on treatment with
hypoglycaemics were considered diabetics.
Multidrug resistance (MDR-TB) was defined as resistance to
both H and R, with or without resistance to other drugs.
Study outcome
The younger and elderly group were compared by gender, body
weight in Kg, literacy rate, employment status, diabetes, asthma,
smoking, alcohol use, respiratory symptoms and its duration, type
of TB, sputum smear status, side effects and drug susceptibility
profile. TB treatment outcomes were compared as; those cured,
treatment completed, failed, loss to follow-up (referred to as
‘default’ in RNTCP nomenclature), died and transferred out.
Data entry and analysis
Data were double-verified, entered and analysed using SPSS
version 14.0 (Statistical Package for the Social Sciences Inc,
Chicago, IL, USA). Variables were expressed as proportions.
Statistical differences between the elderly and younger groups
were determined with chi-square test and Yates correction, except
when expected values of less than 5 required the use of the Fisher
exact test. Significance was determined at 5%. Crude odds ratios
(OR) and 95% confidence intervals (CI) were determined using
‘‘younger’’ as the reference group.
Results
Patient characteristics
From May 1999 through December 2004, 5368 TB patients
were registered for treatment. Patients aged ,15 yrs (n = 65) and
those on non- supervised TB treatment (n = 95) were excluded.
Among the remaining 5208 patients included in the analysis, there
were 865 elderly (60–90 yrs) and 4343 younger (15–59 yrs) TB
patients.
The median age in the elderly group was 65 years (IQR: 60–68)
and younger group was 39 years (IQR: 28–49). The baseline
characteristics of elderly and younger patients are shown in
Table 1. The socio-demographic profile of elderly showed a male
preponderance (84% vs. 71%; p,0.001), higher illiteracy (63% vs.
45%; p,0.001) and unemployment (58% vs. 35%; p,0.001)
(Table 1). The mean body weight was similar in both the groups;
elderly 41 kg (range 24–77 kg) and younger 42 kg (range 21–
94 kg).The proportion of patients who smoked was higher in the
elderly (46% vs. 37%; p,0.001) while the consumption of alcohol
was not different (29% and 30%). Prevalence of reported diabetes
mellitus did not differ in both the groups (6% vs. 5%).
TB symptoms and diagnosis (Table 2)
Pulmonary TB disease (96% vs. 91%; p,0.001) and eligibility
for Category III ie.smear negative and non-severe extra-pulmo-
nary TB (41% vs. 33%; p,0.001) were higher among the elderly
(Table 2)
Of the 834 elderly and 3943 younger pulmonary TB patients,
109 (13%) and 488 (12%) were asymptomatic respectively (OR,
1.06; 95%CI, 0.85–1.34); p = 0.582. Among the symptomatics, a
higher proportion of elderly TB patients (40% vs. 36%; p= 0.021)
reported breathlessness, while cough was similar between the two
groups (84% vs. 83%). (Table 2) The RNTCP definition of a TB
Response to Tuberculosis Treatment among Elderly
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suspect during the period of this study was cough of more than 3
weeks duration. Among the 700 elderly and 3290 younger
pulmonary TB patients who reported cough, duration of $21
days was reported by 627 (89%) of elderly and 2922 (89%)
younger patients; p = 0.56. Among the 336 elderly and 1421
younger patients with breathlessness, duration of $21 days
duration was reported by 296 (88%) of elderly and 1195 (84%)
younger patients; p = 0.07. There was no difference in the
duration of symptoms ($21 days) prior to diagnosis, between the
elderly and younger TB patients
Elderly patients were less likely to contact a private provider as
their first action for relief from respiratory complaints (35% vs.
41%; p= 0.002). (Table 2) The median duration between onset of
symptoms and the first action was 2 weeks (IQR: 1–4) and did not
differ between the elderly and the younger group. Initial sputum
smear negativity (46% vs. 36%; p,0.001) was higher in the elderly
with pulmonary TB.
All the 649 patients identified by active case finding during a
prevalence survey had pulmonary TB. The proportion with
asymptomatic disease was higher among those identified through
active case finding (15% vs. 12%; p= 0.021) compared to passive
case finding. Breathlessness (53% vs. 35%; p,0.001) and
hemoptysis (28% vs. 23%; p,0.01) were higher among those
identified by passive case finding while proportion of those with
cough was similar (83% vs. 85%; p= 0.43) in active and passive
case finding. The proportion of patients with symptoms of $21
days duration was higher in the group identified by active
compared to passive case finding; cough (92% vs. 88%; p,0.01),
breathlessness (90% vs. 84%; p,0.001).Smear negativity rate
(43% vs. 37%; p,0.001) was higher among those identified by
active case finding compared to passive case finding.
Active case finding identified a higher proportion of elderly with
TB (19% vs. 11%; p,0.001). (Table 2) There were no significant
differences between the elderly and younger with respect to
symptoms and their duration in patients detected by active case
finding. The sputum smear negativity rate was similar between the
two groups in active case finding, however sputum smear
negativity rate was higher in elderly in passive case finding (46%
vs. 35%; p,0.001).
Drug resistance, smear conversion and treatment
outcomes in newly diagnosed TB patients
Category I. There were 397 elderly and 2205 younger
patients who were treated with the Category I regimen. Overall
elderly patients had less favorable outcome i.e cured/treatment
completed (71% vs. 80%; p,0.001) with more defaulters (14% vs.
11%; p= 0.09) and deaths (10% vs. 4%; p,0.001).(Table 3) Data
on drug-related problems, due to the bulk of drugs or side effects
was available for 289 elderly and 1648 younger TB patients.
Elderly 183 (63%) reported more problems compared to the
younger 897 (54%); (OR, 1.44; 95%CI, 1.12–1.87); p = 0.005.
Among smear positive patients (352 elderly and 1933 younger),
lower smear conversion rate at the end of IP (77% vs. 85%; p,
0.001) and higher loss to follow-up (15% vs. 11%; p= 0.03) and
death rates (9% vs. 4%; p,0.001) were observed in the elderly.
(Table 3)
Drug susceptibility results were available for the 293 elderly and
1597 younger patients. Similar proportions of patients had
Mycobacterium tuberculosis (M.tb) susceptible to all first line anti-TB
drugs (elderly 87% vs. younger 84%) with no difference in MDR-
TB rates. (Table 3)
Category III. There were 356 elderly and 1447 younger
patients who were treated with the Category III regimen. Elderly
patients were less likely to complete treatment (77% vs. 85%; p,
0,001) and more likely to be lost to follow-up (16% vs. 10%;
p= 0.001). (Table 3)
Among 252 elderly and 1014 younger TB patients with data
available, elderly 95 (38%) reported less drug related problems
compared to the younger group 532 (52%); (OR, 0.55; 95%CI,
0.41–0.73); p,0.0001.
Drug resistance, smear conversion and TB Treatment
outcomes in previously treated TB patients
There were 112 elderly and 691 younger patients who were
treated with the Category II regimen. Treatment outcomes did not
differ between the groups. (Table 4) Drug related problems were
similar; (elderly 38 (48%) vs. younger 261 (55%); (OR, 0.73;
95%CI, 0.46–1.18); p = 0.20 among 80 elderly and 473 younger
patients for whom data was available.
Sputum smear conversion rate at the end of IP in the elderly
was 67% compared to 60% in younger; p = 0.20). Treatment
outcomes did not differ between the two groups. (Table 4). Drug
Table 1. Baseline characteristics of TB patients in the elderly and younger group.
Characteristics Elderly n=865 Younger n=4343 OR (95% CI)
$
P value
n % n %
Male 723 84 3083 71 2.08 (1.72–2.52) ,0.001
Body wt* #40 Kg 385 48 1838 45 1.1(0.96–1.31) 0.13
Illiterate** 541 63 1941 45 2.06 (1.78–2.39) ,0.001
Un-employed 498 58 1506 35 2.56 (2.20–2.97) ,0.001
Co-morbidity
Diabetic** 52 6 206 5 1.28 (0.94–1.76) 0.118
Habits
Smoker** 396 46 1623 37 1.41 (1.22–1.64) ,0.001
Alcohol use** 250 29 1315 30 0.93 (0.79–1.09) 0.415
*Details not available for 55 patients in the elderly group and 222 in the younger.
**Details not available for 2 patients in the younger group.
$
Odds ratio (95% CI) calculated with younger group as reference using chi-square test.
doi:10.1371/journal.pone.0088045.t001
Response to Tuberculosis Treatment among Elderly
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susceptibility profile was available for 66 elderly and 452 younger
patients. Susceptibility to first line anti-TB drugs did not differ
between the groups. MDR-TB rates were lower among the elderly
than in the younger group, but this was not statistically significant
(6% vs. 11%, p= 0.19). (Table 4)
Discussion
TB is emerging as a significant health problem in the elderly
[17] and the control of TB in this group is essential for the overall
success of TB control programmes. This study has documented
that elderly TB patients are less likely to have smear positive
disease and newly diagnosed elderly TB patients are more likely to
default or die and report drug side effects, which is a matter of
concern.
Sputum smear microscopy is the cornerstone of TB diagnosis.
Similar to previous studies [9,12,18], we observed higher initial
sputum smear negativity in the elderly. In support of this, a higher
proportion of elderly patients received the Category III regimen
compared to the younger (41% vs. 33%). In the RNTCP,
diagnosis of smear negative TB is based on the persistence of
respiratory symptoms and/or radiological abnormality despite a
course of antibiotics. We do not have data on the proportion of
patients in this study with radiological abnormality. Sputum
culture is not routinely done in RNTCP and therefore we do not
know the proportion of smear negative patients who were culture
positive. Currently the TB Control programme classifies TB
patients based on history of previous treatment as ‘‘New’’ or
‘‘previously treated’’ and offers only 2 types of regimen - Category
I and II [19]. Nevertheless, the higher initial sputum smear
negativity observed in the elderly may delay the diagnosis of TB.
Table 3. Drug susceptibility profile, Smear conversion and TB Treatment outcomes in newly diagnosed TB patients in the elderly
and younger group.
Elderly Younger OR (95% CI)
$
P value
Category I n =397 n=2205
Overall treatment outcome n % n %
Cured/Treatment Completed 283 71 1770 80 0.61 (0.48–0.78) ,0.001
Failure 17 4 97 4 1.97 (0.54–1.66) 0.92
Loss to follow-up 56 14 247 11 1.30 (0.90–1.80) 0.09
Death 38 10 86 4 2.60 (1.70–3.90) ,0.001
Transferred 3 1 5 ,1 3.75 (0.89–15.79) 0.07
Smear positive PTB n=352 n=1933
Smear conversion at the end of Intensive phase n % n %
Yes 272 77 1651 85 0.58 (0.44–0.77) ,0.001
Culture result available n=336 n=1856
Positive 294 88 1602 86 1.20 (0.80–1.60) 0.55
Drug susceptibility available n=293 n=1597
Sensitive 256 87 1349 84 1.27 (0.87–1.90) 0.20
Any resistance
H 21 7 169 11 0.65 (0.40–1.10) 0.08
SM 21 7 141 9 0.79 (0.47–1.29) 0.35
R 4 1 30 2 0.72 (0.18–2.07) 0.54
HR 3 1 25 2 0.65 (0.12–2.15) 0.48
Treatment outcome of smear positive PTB treated
with Category I
Cured/Treatment completed 248 70 1546 80 0.60 (0.46–0.78) ,0.001
Failure 16 5 96 5 0.91(0.49–1.58) 0.74
Loss to follow-up 54 15 219 11 1.40 (1.0–1.97) 0.03
Death 31 9 68 4 2.60 (1.6–4.20) ,0.001
Transferred 3 1 4 ,1 4.67 (1.04–21.01) 0.04
Category III n = 356 n=1447
Treatment outcome n % n %
Treatment Completed 275 77 1238 85 0.57 (0.43–0.77) ,0.001
Failure 6 2 19 1 1.30 (0.42–3.39) 0.59
Loss to follow-up 56 16 142 10 1.70 (1.20–2.40) 0.001
Death 19 5 45 3 1.81 (0.96–3.11) 0.04
Transferred 0 0 3 ,1 NA -
$
Odds ratio (95% CI) calculated with younger group as reference using chi-square test.
doi:10.1371/journal.pone.0088045.t003
Response to Tuberculosis Treatment among Elderly
PLOS ONE | www.plosone.org 5 March 2014 | Volume 9 | Issue 3 | e88045
TB diagnostic algorithms should include other diagnostic tools
apart from smear microscopy (eg. Xpert MTB/RIF) while
evaluating the elderly for diagnosis of TB.
Smear conversion at the end of IP is an early predictor of
treatment success [20]. Elderly new smear positive TB patients
had lower smear conversion rates at the end of IP in this study
(77% vs. 85%). This is similar to a previous study in which the
sputum conversion rates at the end of the intensive phase were
found to be significantly lower in the elderly in comparison to the
younger TB patients (75.3% vs. 85.7%: p,0.01) [8]. There could
be many reasons for this; including modification of treatment due
to adverse effects of anti-TB drugs and associated illness [8]. The
possibility of malabsorption of anti-TB drugs in the elderly could
also be considered since malabsorption of calcium, folate and
Vitamin B12 has been reported in the elderly [21].
The cure/treatment completion rate among new elderly TB
patients was observed to be 71% in our study which is lower than
the RNTCP objective of 85% cure rate [13]. This can be
attributed to higher death (10%) and loss to follow-up rates (14%).
A recent study from South India has documented a significantly
higher risk (RR-1.4, 95% CI 1.2–1.6) of unfavourable treatment
outcomes in older TB patients (16% compared with 11% for all
others) with a stronger association among new TB patients [7].
Death rate of 8% among new smear positive elderly TB patients
has been documented in previous studies [12,22]. The higher
death rate among elderly TB patients has to be interpreted with
caution since mortality increases with age. Higher mortality
among TB patients aged 70 years or more has been reported [7].
The cause of death in elderly TB patients can be difficult to
determine, as TB may not be the only life-threatening disease and
autopsies are rarely performed [23]. Nevertheless, in a study from
Germany, TB as a post mortem diagnosis was more frequently
established among elderly patients [18].
High loss to follow-up rates of 10.7% and 14.2% in the elderly
were observed in previous studies [8,12] similar to our observation
of 14%. The reasons cited for loss to follow-up in the elderly are
poor memory, poor eyesight, low tolerance to therapy, mental
confusion, associated depression, concomitant illness and logistic
problems for regular visits to treatment centre [8,17]. Loss to
follow-up rate in the elderly could be reduced by ensuring good
quality geriatric health services at the primary care level to address
the various needs of the elderly population. Community geriatric
health workers to provide home care may contribute to better TB
management in the elderly.
We observed similar treatment outcomes among previously
treated elderly and younger TB patients. Loss to follow-up rate
was greater than 35% in these patients. Higher loss to follow-up
rates for re-treatment patients have been documented in previous
Table 4. Drug susceptibility profile, Smear conversion and TB Treatment outcomes in previously treated TB patients in the elderly
and younger group.
Elderly Younger OR (95% CI)
$
P value
Category II n =112 n=691
Overall treatment outcome n % n %
Cured/Treatment Completed 54 48 316 46 1.10 (0.72–1.68) 0.62
Failure 4 4 57 8 0.41 (0.14–1.18) 0.10
Loss to follow-up 40 36 264 38 0.90 (0.60–1.40) 0.61
Death 11 10 47 7 1.50 (0.70–3.00) 0.25
Transferred 3 3 7 1 2.51 (0.63–9.99) 0.19
Smear positive PTB n=97 n=602
Smear conversion at the end of Intensive phase n % n %
Yes 65 67 362 60 1.35 (0.86–2.12) 0.20
Culture result available n=92 n=552
Positive 67 73 453 82 0.60 (0.34–1.02) 0.04
Drug susceptibility available n=66 n=452
Sensitive 42 64 263 58 1.26 (0.72–2.25) 0.40
Any resistance
H 20 30 167 37 0.75 (0.42–1.32) 0.31
SM 8 12 74 16 0.67 (0.30–1.49) 0.33
R 4 6 54 12 0.46 (0.16–1.34) 0.16
HR 4 6 51 11 0.49 (0.17–1.42) 0.19
Treatment outcome of smear positive PTB treated with
Category II
Cured/Treatment completed 46 48 256 43 1.21 (0.77–1.91) 0.37
Failure 4 4 56 9 0.42 (0.11–1.18) 0.09
Loss to follow-up 36 37 245 41 0.90 (0.50–1.40) 0.50
Death 9 9 38 6 1.60 (0.60–3.30) 0.28
Transferred 2 2 7 1 1.59 (0.32–7.87) 0.57
$
Odds ratio (95% CI) calculated with younger group as reference using chi-square test.
doi:10.1371/journal.pone.0088045.t004
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studies [12,24]. Adverse effects to anti-TB drugs either due to the
bulk or toxicity was higher in elderly new TB patients (63% vs.
54%) in this study. A study from Korea documented higher drug-
induced hepatitis, cutaneous toxicity, neurotoxicity, gastrointesti-
nal disturbances, arthralgia, and flu-like syndrome in the elderly
[25]. Advancing age as an important predictor of hepatotoxicity
due to H and R has been documented [26,27]. Polypharmacy and
age-related changes in responses to drugs and their elimination
due to compromised hepatic and renal functions, contribute to
drug adverse effects [26]. Health care workers need to be aware of
potential drug adverse effects for prompt intervention and
appropriate management.
M.tb drug resistance rates were marginally lower, though not
statistically significant, among elderly compared to younger
patients, both among new and previously treated patients in this
study. This is similar to a previous study which documented no
significant differences in isoniazid-resistant TB and MDR TB
between the two age groups [28]. Analysis of TB notification data
from Germany documented markedly lower drug resistance rates
in the elderly for any drug resistance (6.5% vs 13.9%; p,0.001)
and for MDR (0.6% vs. 3.1%; p,0.001) [18]. The reason for this
phenomenon could be that TB disease in the elderly is largely due
to re-activation of infection acquired in the distant past when drug
resistant rates were lower.
Pulmonary TB (PTB) was common in the elderly in our study.
This is in conformity with previous studies which documented
higher prevalence of PTB in the elderly [8,12]. Pulmonary TB is a
disease with male preponderance. Higher proportion of males in
the elderly observed in our study is similar to previous reports
[8,9].
Smoking is a risk factor for the development of TB [29]. A
higher proportion of elderly males (46%vs 37%) were smokers in
this study. A study from Amritsar among hospitalised TB patients
showed no difference in smoking between the elderly and younger
[10] while a descriptive study in a cohort of 100 patients aged .
50 yrs from Himachal Pradesh documented 68% smoking [11].
Smoking cessation interventions focusing on the elderly will be
important to reduce the burden of complications due to TB.
Associated co-morbidities in the elderly are a challenge to both
TB diagnosis and treatment. We observed similar prevalence of
diabetes mellitus in both age groups. Prevalence of co-morbidities
namely cardiovascular diseases, diabetes mellitus, and airway
obstructive disease has been reported to be higher in older TB
patients [28].
A systematic review documented old age as a risk factor for TB
diagnostic delay, with factors such as poverty, social isolation, and
specific health-seeking behaviour hampering the elderly in gaining
timely access to medical care [30]. We observed 63% illiteracy and
a higher case detection rate by active case finding (through survey)
in the elderly. In addition, the elderly were economically
dependent, as 58% were unemployed which implies that family
support was necessary for medical help. Organizing frequent TB
screening camps and other methods for active case finding, mobile
clinics and increasing awareness through mass media may
enhance early TB case detection in the elderly.
The limitations of our study include the possibility of potential
misclassification of some Category II as Category I patients due to
concealed history of previous anti-TB treatment at the time of
diagnosis. The information on some important risk factors, such as
HIV infection that could influence treatment outcomes was not
available. Diabetes was self reported and this probably contributed
to its lower prevalence. In addition, we were unable to collect
more details pertaining to toxicity of anti-TB treatment and
investigate the cause of death. Data for radiological extent of
disease and the exact duration of symptoms prior to diagnosis were
not available.
In summary, our study has shown that elderly TB patients are
less likely to have smear positive disease though the majority had
pulmonary TB. Newly diagnosed elderly TB patients are more
likely to be lost to follow-up or die and report drug side effects.
Programme managers should develop appropriate interventions in
consultation with geriatric specialists, for effective management of
TB in this vulnerable population.
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